Journal article
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
Abstract
PURPOSE: Serous adenocarcinoma is a rare, aggressive histologic subtype of endometrial cancer with a high rate of recurrence and a poor prognosis. The optimal adjuvant treatment for early-stage patients is unclear. Our objective was to evaluate the outcomes of stage IA serous endometrial cancers only treated at a single institution and determine whether our current approach of chemotherapy plus vaginal brachytherapy (VBT) is sufficient.
Authors
Donovan E; Reade CJ; Eiriksson LR; Pond GR; Arora N; Elit L; Memon S; Voruganti S; Patel M; Jimenez W
Journal
Cureus, Vol. 10, No. 9,
Publisher
Springer Nature
Publication Date
September 29, 2018
DOI
10.7759/cureus.3387
ISSN
2168-8184